A brief history of menopause and hormone therapy

Making sense of the results

Women in the study were older, predisposing them to disease

They were many years past their last period and had no current menopausal symptoms

Today, the limitations in the design of the original trial are acknowledged, but the results remain important to how hormone therapy is prescribed today. Researchers were able to better see the risks involved with long-term use of higher doses of estrogen in older patients.² This study and its observations were the basis for safety information for all estrogen therapies regardless of the route of administration.

After several years of evaluation, hormone therapy has re-established its position as an important option for women experiencing menopausal symptoms. Doctors agree that hormone therapy should always be used at the lowest effective dose for the shortest amount of time needed to control the symptoms of menopause.^1,5

» Footnote References

» Previous page

Important Safety Information

Evamist^® is approved by the FDA for use after menopause to reduce moderate-to-severe hot flashes.

Estrogens increase the chance of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are using Evamist. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus. Your healthcare provider should check any unusual vaginal bleeding to find out the cause.

Do not use estrogens with or without progestins to prevent heart disease, heart attacks, strokes, or dementia. Using estrogens, with or without progestins, may increase your chance of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogen, with or without progestins, may increase your risk of dementia, based on a study of women age 65 years or older. Evamist should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the past year; currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.

The most common side effects that may occur with Evamist are headache, breast tenderness, the common cold, nipple pain, back pain, nausea, and joint pain.

You and your healthcare provider should talk regularly about whether you still need treatment with Evamist.

Please see full prescribing information for Evamist.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.